HAVN Life Sciences Inc. (CSE: HAVN | OTC: HAVLF | FSE: 5NP), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that Alpha Blue Ocean is supporting the Company’s growth with a CAD$9,000,000 financing arrangement whereby the Company will issue up to $10.6 million principal amount of Convertible Debentures…